Siirry offline-tilaan Player FM avulla!
02_03 Adjuvant endocrine therapy for early breast cancer
Manage episode 345612737 series 3335024
1. Tamoxifen, its development, mechanism and benefits
2. Aromatase inhibitors and their benefit in post-menopausal state
3. Nuances on extended endocrine therapy beyond 5 years
4. SOFT/TEXT, a broad overview of a complex publication
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references on this topic:
1. Pagani O et al.. NEJM. 2014;371(2):107-118. doi:10.1056/NEJMOA1404037
2. Francis PA et al. NEJM. 2018;379(2):122-137. doi:10.1056/NEJMOA1803164/
3. Gnant M et al. NEJM. 2021;385(5):395-405. doi:10.1056/NEJMOA2104162/
4. Cuzick J et al. Lancet Oncol. 2010;11(12):1135-1141. doi:10.1016/S1470-2045(10)70257-6
5. Regan MM et al. Lancet Oncol. 2011;12(12):1101-1108. doi:10.1016/S1470-2045(11)70270-4
6. Davies C et al.. The Lancet. 2013;381(9869):805-816. doi:10.1016/S0140-6736(12)61963-1
7. Goss PE et al. NEJM. 2016;375(3):209-219. doi:10.1056/NEJMOA1604700/
8. Goss PE et al. J Natl Cancer Inst. 2005;97(17):1262-1271. doi:10.1093/JNCI/DJI250
9. Abe O et al. The Lancet. 2011;378(9793):771-784. doi:10.1016/S0140-6736(11)60993-8
10. Jordan VC. A Breast Cancer Research. 2003;5(6):294. doi:10.1186/BCR656
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
Tags
Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
48 jaksoa
02_03 Adjuvant endocrine therapy for early breast cancer
Talking About Tumors with Ryann and Ryan - A medical oncology podcast
Manage episode 345612737 series 3335024
1. Tamoxifen, its development, mechanism and benefits
2. Aromatase inhibitors and their benefit in post-menopausal state
3. Nuances on extended endocrine therapy beyond 5 years
4. SOFT/TEXT, a broad overview of a complex publication
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references on this topic:
1. Pagani O et al.. NEJM. 2014;371(2):107-118. doi:10.1056/NEJMOA1404037
2. Francis PA et al. NEJM. 2018;379(2):122-137. doi:10.1056/NEJMOA1803164/
3. Gnant M et al. NEJM. 2021;385(5):395-405. doi:10.1056/NEJMOA2104162/
4. Cuzick J et al. Lancet Oncol. 2010;11(12):1135-1141. doi:10.1016/S1470-2045(10)70257-6
5. Regan MM et al. Lancet Oncol. 2011;12(12):1101-1108. doi:10.1016/S1470-2045(11)70270-4
6. Davies C et al.. The Lancet. 2013;381(9869):805-816. doi:10.1016/S0140-6736(12)61963-1
7. Goss PE et al. NEJM. 2016;375(3):209-219. doi:10.1056/NEJMOA1604700/
8. Goss PE et al. J Natl Cancer Inst. 2005;97(17):1262-1271. doi:10.1093/JNCI/DJI250
9. Abe O et al. The Lancet. 2011;378(9793):771-784. doi:10.1016/S0140-6736(11)60993-8
10. Jordan VC. A Breast Cancer Research. 2003;5(6):294. doi:10.1186/BCR656
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
Tags
Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology
48 jaksoa
Kaikki jaksot
×Tervetuloa Player FM:n!
Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.